Article citationsMore>>

Kim, J., Singh, H., Ayalew, K., Borror, K., Campbell, M., Johnson, L.L., Karesh, A., Khin, N.A., Less, J.R., Menikoff, J., Minasian, L., Mitchell, S.A., Papadopoulos, E.J., Piekarz, R.L., Prohaska, K.A., Thompson, S., Sridhara, R., Pazdur, R. and Kluetz, P.G. (2018) Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections. Clinical Cancer Research, 24, 1780-1784.
https://doi.org/10.1158/1078-0432.CCR-17-2555

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top